Subcutaneous Low-Molecular Weight Heparin or Oral Anticoagulants for the Prevention of Deep-Vein Thrombosis in Elective Hip and Knee Replacement?

Hamulyák, Karly; W.A. Lensing, Anthonie; van der Meer, Jan; M. Smid, W.; van Ooy, A.; A Hoek, Jaap; the Fraxiparine Oral Anticoagulant Study Group, for

doi:10.1055/s-0038-1649959

Public

Subcutaneous Low-Molecular Weight Heparin or Oral Anticoagulants for the Prevention of Deep-Vein Thrombosis in Elective Hip and Knee Replacement?

Published in Thrombosis and Haemostasis • Jan 1, 1995

Authors:

Karly Hamulyák

Anthonie W.A. Lensing

Jan van der Meer

Abstract

OBJECTIVE: To compare efficacy, safety, and feasibility of adjusted-dose oral anticoagulants (OAC) versus fixed-dose subcutaneous low molecular weight heparin (LMWH) for the prevention of deep venous thrombosis (DVT) in patients who have undergone elective hip or knee replacement. DESIGN: Multicentr...

Subject

Medicine

Pulmonary embolism

Venography

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!